Navigating climate-focused AI funding offers a unique milestone for turning research concepts into transformative tools. CEO Aaron Schacht describes how BiomEdit’s Bezos-funded “digital twin” work aims to model genetics, feed and microbiome to predict performance and methane reduction, creating a platform that could serve both producers and future commercial partners.

Harnessing the power of real-world evidence is critical to scaling precision medicine. Christina Lopes, Co-Founder & CEO of FidoCure, shares how the company built a canine cancer dataset and leveraged AI to transform data points into targeted therapies, driving adoption beyond oncology specialists and enabling validated and scalable solutions.

Early market entry is often necessary to generate revenue and support the commercialisation of innovation. Jasdeep Singh, CEO of SingleTimeMicroneedles, explains how his company bridged the financing gap through navigating alternatives to traditional regulatory and go-to-market strategies.